ALIAN s.r.o.
About ALIAN s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Bayer
4
Celgene
4
Pfizer
4
Abivax S.A.
2
Amgen
2
Arena Pharmaceuticals
2
ALK-Abelló A/S
1
Cogentus Pharmaceuticals
1
Daiichi Sankyo, Inc.
1
Eli Lilly and Company
1
Gilead Sciences
1
Clinical Trials at ALIAN s.r.o.
During the past decade, ALIAN s.r.o. conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 12 clinical trials were completed, i.e. on
average, 52.2% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 7 clinical trials were completed. i.e. 77.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
2007-12-01
2009-11-01
Terminated
5,000
Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina
2011-09-01
2012-10-01
Completed
949
A Study of Lebrikizumab in Participants With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and a Second Controller Medication
2013-07-31
2017-01-02
Completed
1,081
The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-03-22
Terminated
16,784
The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects
2013-10-29
2017-04-03
Terminated
10,564
Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis
2015-06-17
2020-06-17
Completed
1,012
An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis
2015-12-02
2025-02-27
Active, not recruiting
878
Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD
2015-11-01
2021-06-21
Completed
2,425
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "ALIAN s.r.o." #1 sponsor was "Bayer" with 4 trials, followed by "Celgene" with 4 trials
sponsored, "Pfizer" with 4 trials sponsored, "Abivax S.A." with 2 trials sponsored and "Amgen"
with 2 trials sponsored. Other sponsors include 7 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "ALIAN s.r.o."
#1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Brigham and Women's Hospital" with 1 trials as a collaborator, "ICON plc" with 1 trials as a collaborator, "Medidata Solutions" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at ALIAN s.r.o.
According to Clinical.Site data, the most researched conditions in "ALIAN s.r.o." are
"Ulcerative Colitis" (9 trials), "Coronary Artery Disease" (3 trials), "Crohn's Disease" (3 trials), "Atrial Fibrillation" (2 trials) and "Cardiovascular Disease" (2 trials). Many other conditions were trialed in "ALIAN s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at ALIAN s.r.o.
Most popular intervention types in "ALIAN s.r.o." are "Drug" (26 trials), "Other" (3 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (18 trials), "Etrasimod" (4 trials), "GED-0301" (2 trials), "RPC1063" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.
Clinical Trials Genders at ALIAN s.r.o.
The vast majority of trials in "ALIAN s.r.o." are
28 trials for "All" genders.
Clinical Trials Status at ALIAN s.r.o.
Currently, there are NaN active trials in "ALIAN s.r.o.".
undefined are not yet recruiting,
5 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 12 completed trials in ALIAN s.r.o.,
undefined suspended trials,
and 7 terminated clinical trials to date.
Out of the total trials that were conducted in ALIAN s.r.o., 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 19 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 2 trials that are defined as “Not Applicable".